Delivery Order SPE2DB24D9222-SPE2DB24FAZDK
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the supply of FASENRA PEN 30 MG/MLML, a pharmaceutical product. This delivery order is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,275.00, is for the delivery of FASENRA PEN 30 MG/ML medical supplies. The contract is a firm fixed-price delivery order, without any set-aside designation. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $2,275.00 and an ultimate completion date of March 19, 2025. The contract is for the delivery of FASENRA PEN 30 MG/MLML, a pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,330.50 firm fixed-price delivery order is for the supply of FASENRA 30 MG/ML SYRINGEML, a pharmaceutical product, with a contract completion date of June 24, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $7,330.50, is for the delivery of FASENRA PEN 30 MG/MLML, a pharmaceutical product, with a completion date of May 20, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with DLA, valued up to $499,999,999, which allows the agency to issue firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,443.50 firm fixed-price delivery order is for the supply of FASENRA 30 MG/ML SYRINGEML and has a completion date of July 17, 2024. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,275.00, is for the delivery of FASENRA PEN 30 MG/MLML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract...
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $4,887.00 firm fixed-price contract is for the delivery of the pharmaceutical product FASENRA PEN 30 MG/MLML to support the medical supply needs of the U.S. Department of Defense. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract with the DLA to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,330.50, is a firm fixed-price delivery order for the supply of FASENRA 30 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of August 16, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,661.00 to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of FASENRA 30 MG/ML SYRINGEML, a specialty pharmaceutical product, with a performance period running through September 5, 2024. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that...
- SPE2DB24D9222Indefinite Delivery Contract
- SPE2DB24D9222-SPE2DB24FAZDKDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,887.00, is for the delivery of FASENRA PEN 30 MG/MLML. The award is a delivery order under an existing indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at up to $499,999,999. This single-award IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation. Through this contract, DMS Pharmaceutical Group will provide a wide variety of pharmaceutical products, including both common and specialized medications, to support the diverse medical needs of military personnel and their dependents across various Department of Defense (DoD) healthcare facilities. The contract has a completion date of June 10, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 6/7/24 |